Total Number of Drug- and Alcohol-Related Intoxication Deaths Occurring in Maryland, 2007-2016.

These data show total annual Maryland drug intoxication deaths from 2007 to 2016, broken down by substance. Since an intoxication death may involve more than one substance, counts of deaths related to specific substances do not sum to the total number of deaths. Benzodiazepine deaths include deaths caused by benzodiazepines and related drugs with similar sedative effects.

A listing of each accidental death associated with drug overdose in Connecticut from 2012 to 2023. A "Y" value under the different substance columns indicates that particular substance was detected. Data are derived from an investigation by the Office of the Chief Medical Examiner which includes the toxicity report, death certificate, as well as a scene investigation. The “Morphine (Not Heroin)” values are related to the differences between how Morphine and Heroin are metabolized and therefor detected in the toxicity results. Heroin metabolizes to 6-MAM which then metabolizes to morphine. 6-MAM is unique to heroin, and has a short half-life (as does heroin itself). Thus, in some heroin deaths, the toxicity results will not indicate whether the morphine is from heroin or prescription morphine. In these cases the Medical Examiner may be able to determine the cause based on the scene investigation (such as finding heroin needles). If they find prescription morphine at the scene it is certified as “Morphine (not heroin).” Therefor, the Cause of Death may indicate Morphine, but the Heroin or Morphine (Not Heroin) may not be indicated. “Any Opioid” – If the Medical Examiner cannot conclude whether it’s RX Morphine or heroin based morphine in the toxicity results, that column may be checked

A. SUMMARY This dataset includes data from the Office of the Chief Medical Examiner on the number of preliminary unintentional fatal drug overdoses per month. B. HOW THE DATASET IS CREATED The Office of the Chief Medical Examiner releases a monthly report containing the previous month’s preliminary count of unintentional fatal drug overdoses. This dataset is manually updated based on that report. The San Francisco Office of the Chief Medical Examiner (OCME) investigates any unknown cause of death for deaths that occur in San Francisco. OCME uses drug testing, death scene investigation, autopsy, medical record, and informant information to determine the cause of death. Preliminary determinations are generally based on drug testing and death scene investigations. Preliminary deaths reported by the medical examiner consist of two categories: (a) cases that are still under investigation and involve suspected acute toxicity from opioids, cocaine, or methamphetamine; and (b) cases that have been finalized and were attributed to acute toxicity from any substance (including prescribed medication and over-the-counter medication). C. UPDATE PROCESS This dataset is updated monthly following the release of the monthly accidental fatal drug overdose report from the Office of the Chief Medical Examiner. Department of Public Health staff manually copy data from the Office of the Chief Medical Examiner’s report to update this dataset. D. HOW TO USE THIS DATASET This dataset is updated each month to include the most recent month’s preliminary accidental fatal drug overdose count. Counts from previous months are often also updated as it can take more than a month for the Office of the Chief Medical Examiner to finish reviewing cases. E. RELATED DATASETS San Francisco Department of Public Health Substance Use Services Overdose-Related 911 Responses by Emergency Medical Services (EMS) Unintentional Drug Overdose Death Rate by Race/Ethnicity

**Static Data Set** This table shows opiate overdoses by race for Fiscal Year 2018.

**Static Data Set** Opiate overdoses treated by EMS by drug type for fiscal year 2018

**Static Data Set** Opiate overdoses by age group and gender for fiscal year 2018

This data presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System. Counts for the most recent final annual data are provided for comparison. National provisional counts include deaths occurring within the 50 states and the District of Columbia as of the date specified and may not include all deaths that occurred during a given time period. Provisional counts are often incomplete and causes of death may be pending investigation resulting in an underestimate relative to final counts. To address this, methods were developed to adjust provisional counts for reporting delays by generating a set of predicted provisional counts. Several data quality metrics, including the percent completeness in overall death reporting, percentage of deaths with cause of death pending further investigation, and the percentage of drug overdose deaths with specific drugs or drug classes reported are included to aid in interpretation of provisional data as these measures are related to the accuracy of provisional counts. Reporting of the specific drugs and drug classes involved in drug overdose deaths varies by jurisdiction, and comparisons of death rates involving specific drugs across selected jurisdictions should not be made. Provisional data presented will be updated on a monthly basis as additional records are received. For more information please visit: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm